NHS ‘not ready’ for new Alzheimer’s drugs

Image source, Getty Images By Fergus Walsh Medical editor Alzheimer’s patients could lose out on two groundbreaking new drugs because the NHS is unprepared, a leading charity has told BBC Panorama. Lecanemab and donanemab slow down the early stages of the disease – which is the most common form of dementia. But Alzheimer’s Research UK says the NHS is not ready to roll out the drugs, which could be licensed,

from the BBC

Read More